Efficacy and safety of 3- and 5-injection patterns (30 and 50 U) of botulinum toxin A (dysport) for the treatment of wrinkles in the glabella and the central forehead region

Archives of Dermatology

Volumn 142, Issue 3, 2006, Pages 320-326

  Rzany, Berthold ^a   Ascher, Benjamin ^c   Fratila, Alina ^b   Monheit, Gary D ^d   Talarico, Sergio ^e   Sterry, Wolfram ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Jungbrunnen Klinik Dr Fratila GmbH   (Germany)

^c Clinique Iena   (France)

^d Dermatology Associates   (United States)

^e FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; PLACEBO;

ADULT; ARTICLE; CONTROLLED STUDY; FACE MUSCLE; FEMALE; FOREHEAD; GERMANY; HUMAN; INJECTION SITE; MAJOR CLINICAL STUDY; MALE; PATIENT SATISFACTION; PHOTOGRAPHY; PRIORITY JOURNAL; SAFETY; WRINKLE;

ADOLESCENT; ADULT; AGED; BOTULINUM TOXIN TYPE A; COSMETIC TECHNIQUES; DOUBLE-BLIND METHOD; FACIAL MUSCLES; FEMALE; FOREHEAD; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; MIDDLE AGED; NEUROMUSCULAR AGENTS; PATIENT SATISFACTION; SKIN AGING;

EID: 33645101770     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.142.3.320     Document Type: Article

References (13)

1. Ascher B, Zakine B, Kestemont P, Baspeyras M, Bougara A, Santini J. A multicenter, randomized, double blind, placebo-controlled study of efficacy and safety of three doses of botulinum toxin A in the treatment of glabellar lines. J Am Acad Dermatol. 2004;51:223-233.
2. Carruthers A, Carruthers J, Cohen J. A prospective, double-blind, randomized, parallel-group, dose-ranging study of botulinum toxin type A in female subjects with horizontal forehead rhytides. Dermatol Surg. 2003;29:461-467.
3. Carruthers JD, Lowe NJ, Menter MA, Gibson J, Eadie N; Botox Glabellar Lines II Study Group. Double-blind, placebo-controlled study of the safety and efficacy of botulinum toxin type A for patients with glabellar lines. Plast Reconstr Surg. 2003;112:1089-1098.
4. Rzany B. Bericht zum 1: Expertentreffen zur Anwendung von Botulinumtoxin A in der Ästhetischen Dermatologie [First meeting of experts: botulinum toxin A in aesthetic dermatology]. Kosmetische Medizin. 2003;24:2-8.
5. Heckmann M, Ceballos-Baumann AO, Plewig G. Botulinum toxin A for axillary hyperhidrosis (excessive sweating). N Engl J Med. 2001;344:488-493.
6. Schnider P, Binder M, Auff E, Kittler H, Berger T, Wolff K. Double-blind trial of botulinum A toxin for the treatment of focal hyperhidrosis of the palms. Br J Dermatol. 1997;136:548-552.
7. Schnider P, Morau E, Kittler H, et al. Treatment of focal hyperhidrosis with botulinum toxin type A: long-term follow-up in 61 patients. Br J Dermatol. 2001;145:289-293.
8. Heckmann M, Rzany B, eds. Botulinumtoxin in der Dermatologie: Grundlagen und Praktische Anwendung. München, Germany: Urban und Vogel; 2002.
9. Feller G, Bayerl C, Jung EG, Rzany B. Korrektur der dynamischen Gesichtsfalten mit Botulinum toxin A (Dysport®): eine Pilotstudie [Correction of mimic wrinkles with botulinum toxin A (Dysport)]. Akt Dermatol. 2000;26:65-69.
10. Sampaio C, Costa J, Ferreira JJ. Clinical comparability of marketed formulations of botulinum toxin. Mov Disord. 2004;19(suppl 8):S129-S136.
11. Honeck P, Weiss C, Sterry W, Rzany B; GLADYS Study Group. Reproducibility of a four-point clinical severity score for glabellar frown lines. Br J Derm. 2003;149:306-310.
12. Loos BM, Maase CS. Relevant anatomy for botulinum toxin facial rejuvenation. Facial Plast Surg Clin North Am. 2003;11:439-443.
13. Carruthers JA, Lowe JN, Menter MA. A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines. J Am Acad Dermatol. 2002;46:840-849.